Recall Roundup: April 2026
April’s FDA recalls included everything from insulin pods to wheelchairs.
• 3 min read
Paging all medical professionals: You should know about recent medical device recalls.
The FDA gets 2+ million reports of deaths, injuries, and malfunctions associated with medical devices annually. The agency categorizes recalls of these devices—which can range from small corrections to requests for products to be destroyed—from Class III (least dangerous) to Class I (most dangerous).
We keep you informed on recent Class I recalls here in our ongoing series: Recall Roundup. Here are April’s.
Bubble, bubble toil and trouble. Certain Streamline Airless System Hemodialysis Bloodlines and B3 Low Volume Bloodlines from B. Braun Medical should only be used if there’s no available alternative, according to a March 19 letter from the company.. B. Braun warned that there’s an elevated risk of small air bubbles accumulating in the line.
Cybersecurity risk. Whill Model C2 electric wheelchairs and Model F power chairs are vulnerable to cyberattacks because Bluetooth connection to the chairs doesn’t require authentication, meaning anyone could take over the wheelchair if they’re within range, per the US cybersecurity and infrastructure security agency. In a March 23 customer notice, Whill asked users to download a firmware update that will turn off Bluetooth until Whill can get FDA clearance for a new software version that fixes this vulnerability.
Diabetes danger. Several lots of Omnipod 5 pods may have tears that prevent enough insulin from being delivered, manufacturer Insulet warned customers on March 12. Insulet has reported 29 associated serious injuries as of April 17, per the FDA. Customers can visit the website to see if their pod is affected.
Pacemaker problems. There’s a new recall related to Boston Scientific pacemakers. The company sent users a letter on March 19 about a new software update that fixes an issue raised in previous recalls over battery failures that caused some pacemakers to enter safety mode, a defect connected to at least seven deaths and 800+ injuries, per the New York Times. The company noted it’s extending this warning to more types of pacemakers than in previous recalls.
Syringe issue. Medline has reported four serious injuries as of March 13 in connection with its Namic angiographic rotating adaptor control syringes. The syringes may become loose or disconnect from their manifold during use and should be destroyed unless they are the only option in an emergency, the company warned users in a Feb. 27 letter.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
About the author
Caroline Catherman
Caroline Catherman is a reporter at Healthcare Brew, where she focuses on major payers, health insurance developments, Medicare and Medicaid, policy, and health tech.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.